| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
phenotype | 0.100 | None | 1.000 | 12 | 1 | 2011 | 2018 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FXYD domain containing ion transport regulator 5 | 0.615 | 0.577 | 2.1E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
C-C motif chemokine ligand 4 | 0.466 | 0.923 | 0.24 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
sterol O-acyltransferase 1 | 0.424 | 0.846 | 7.4E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
zeta chain of T cell receptor associated protein kinase 70 | 0.497 | 0.769 | 0.88 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BORA aurora kinase A activator | 0.931 | 0.115 | 3.3E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
C-C motif chemokine ligand 4 like 1 | 0.534 | 0.885 | 0.34 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
grancalcin | 0.590 | 0.731 | 1.4E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |